Find Lawyers Today, Get Legal Help.
Home >> Legal News >> RECALLS AND SAFETY ALERTS WARNING ON NEUROPSYCHIATRIC EFFECTS FROM SMOKING CESSATION DRUGS
FDA News
BACK TO LAWYER CENTRAL LEGAL NEWS CENTER
RECALLS AND SAFETY ALERTS WARNING ON NEUROPSYCHIATRIC EFFECTS FROM SMOKING CESSATION DRUGS
August 31, 2009
FDA is requiring that two drugs used to help people stop smoking carry new warnings about the risk of serious neuropsychiatric effects. The drugs are Chantix (varenicline) and Zyban (bupropion). The same warnings will be required for other bupropio...Related FDA Stories:
- Recalls and Safety Alerts Warning on Neuropsychiatric Effects from Smoking ..
- New Medical Products New Rapid Test for Malaria..
- Recalls and Safety Alerts Recall of Sprint Fidelis Cardiac Leads..
Additional Legal Resources:
Complete the Form Below and Talk to Experienced Lawyers
